This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2014 Remove Pharmaceutical manufacturing Remove Physicians Related Topics
Safety Specialization Leads Healthcare Pharma Networking Patients FDA Retail Transportation More Related Topics >
article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

AUGUST 12, 2022

Data were mainly accessible for smaller firms, products in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products between 2014 and 2018. The most telling data on a disconnect between drug prices and research costs has received almost no public attention.

Pharma 255
Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255
article thumbnail

How one pharma “family business” places patients first

pharmaphorum

OCTOBER 26, 2022

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We This design will enable physicians to take more informed and robust treatment decisions than in most other cases,” Chiesi said. He serves as a Board Member on the Board of the Chiesi Group.

Patients 80
Patients Pharma Consulting Transportation 80
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024